Consequences of bile salt biotransformations by intestinal bacteria

Gut Microbes

Volumn 7, Issue 1, 2016, Pages 22-39

  Ridlon, Jason M ^a   Harris, Spencer C ^b   Bhowmik, Shiva ^c   Kang, Dae Joong ^b   Hylemon, Phillip B ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

bile acid 7 dehydroxylation; bile acid oxidoreductases; bile salt hydrolase; gut microbiota; secondary bile acids

Indexed keywords

AMINO ACID; BILE ACID; CELL NUCLEUS RECEPTOR; G PROTEIN COUPLED RECEPTOR; HYDROLASE; HYDROXYSTEROID DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SHORT CHAIN FATTY ACID; URSODEOXYCHOLIC ACID; VITAMIN D RECEPTOR; CELL RECEPTOR;

BACTERIAL COLONIZATION; BIFIDOBACTERIUM BIFIDUM; BILE ACID SYNTHESIS; BIOTRANSFORMATION; CORONARY ARTERY DISEASE; DETOXIFICATION; DNA DAMAGE; DNA REPAIR; EPIMERIZATION; ESTERIFICATION; GENE SEQUENCE; HYPERCHOLESTEROLEMIA; INTESTINE FLORA; KNOCKOUT GENE; METABOLIC REGULATION; MINIMUM INHIBITORY CONCENTRATION; PEPTOCLOSTRIDIUM DIFFICILE; REVIEW; SCLEROSING CHOLANGITIS; SIZE EXCLUSION CHROMATOGRAPHY; BACTERIUM; DIET; ENERGY METABOLISM; HUMAN; METABOLISM; PHYSIOLOGY;

AMINO ACIDS; BACTERIA; BILE ACIDS AND SALTS; DIET; ENERGY METABOLISM; GASTROINTESTINAL MICROBIOME; HUMANS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84960375270     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2015.1127483     Document Type: Review

References (126)

1. W.G.Hardison. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 1978; 75(1):71–5; PMID:401099
2. P.A.Dawaon, S.J.Karpen. J Lipid Res 2015; 56(6):1085–99; PMID:25210150; http://dx.doi.org/10.1194/jlr.R054114
3. M.Makishima, A.Y.Okamoto, J.J.Repa, H.Tu, R.M.Learned, A.Luk, M.V.Hull, K.D.Lustig,, D.J.Mangelsdorf,, B.Shan. Identification of a nuclear receptor for bile acids. Science 1999; 284:1362–5; PMID:10334992; http://dx.doi.org/10.1126/science.284.5418.1362
4. D.J.Parks, S.G.Blanchard, R.K.Bledsoe, G.Chandra, T.G.Consler, S.A.Kliewer, J.B.Stimmel, T.M.Wilson, A.M.Zavacki, D.D.Moore, Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284:1365-8.
5. Y.Kawamata, Y.FujiiR, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y et al. A G-protein-coupled receptor responsive to bile acids. J Biol Chem 2003; 278:9435–40
6. T.Li, J.Y.Chiang. Bile acids as metabolic reglators. Curr Opin Gastroenterol 2015; 31(2):159–65; PMID:25584736; http://dx.doi.org/10.1097/MOG.0000000000-000156
7. E.D'Aldebert, M.J.Biyeyeme Bi Mve, M.Mergey, D.Wendum, D.Firrincieli, A.Coilly, L.Fouassier, C.Corpechot, R.Poupon, C.Housset, Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology 2009; 136(4):1435–43; PMID:19245866; http://dx.doi.org/10.1053/j.gastro.2008.12.040
8. J.M.Ridlon, D.J.Kang, P.B.Hylemon. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47(2):241–59; PMID:16299351; http://dx.doi.org/10.1194/jlr.R500013-JLR200
9. Y.Alnouti, I.L.Csanaky, C.D.Klaassen. Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 873(2):209–17; PMID:18801708; http://dx.doi.org/10.1016/j.jchromb.2008.08.018
10. rd edition. Vol. 1. D.Zakim and T.Boyer, editors. Saunders, Philadelphia, PA. 1996. 376–417.
11. J.Sjövall. Dietary glycine and taurine on bile acid conjugation in man:bile acids and steroids 75. Proc Soc Exp Biol Med 1959; 100:676–78; PMID:13645682; http://dx.doi.org/10.3181/00379727-100-24741
12. R.Gopal-Srivastava, P.B.Hylemon. Purification and characterization of bile salt hydrolase from Clostridium perfringens. J Lipid Res 1988; 29(8):1079–85; PMID:2903208
13. N.Masuda. Deconjugation of bile salts by Bacteroides and Clostridium. Microbiol Immunol 1981; 25(1):1–11; PMID:6265737; http://dx.doi.org/10.1111/j.1348-0421.1981.tb00001.x
14. A.Wijaya, A.Hermann, H.Abriouel, I.Specht, N.M.Yousif, W.H.Holzapfel, C.M.Franz. Cloning of the bile salt hydrolase (bsh) gene from Enterococcus faecium FAIR-E 345 and chromosomal location of bsh genes from food enterococci. J Food Prot 2004; 67(12):2772–8; PMID:15633685
15. P.Jarocki, Z.Targoński. Genetic diversity of bile salt hydrolases among human intestinal bifidobacteria. Curr Microbiol 2013; 67(3):286–92; PMID:23591474; http://dx.doi.org/10.1007/s00284-013-0362-1
16. H.Tanaka, H.Hashiba, J.Kok, I.Mierau. Bile salt hydrolase of Bifidobacterium longum biochemical and genetic characterization. Appl Environ Microbiol 2000; 66(6):2502–12; PMID:10831430; http://dx.doi.org/10.1128/AEM.66.6.2502-2512.2000
17. H.K.Oh, J.Y.Lee, S.J.Lim, M.J.Kim, J.H.Kim, S.K.Hong, D.K.Kang. Molecular cloning and characterization of a bile salt hydrolase from Lactobacillus acidophilus PF01. J Microbiol Biotechnol 2008; 18(3):449-56.1; PMID:18388461
18. I.De Smet, L.Van Hoorde, M.Vande Woestyne, H.Christiaens, W.Verstraete. Significance of bile salt hydrolytic activities of lactobacilli. J Appl Bacteriol 1995; 79(3):292–301; PMID:7592123; http://dx.doi.org/10.1111/j.1365-2672.1995.tb03140.x
19. E.J.Stellwag, P.B.Hylemon. Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis. Biochim Biophys Acta 1976; 452(1):165–76; PMID:10993; http://dx.doi.org/10.1016/0005-2744(76)90068-1
20. B.V.Jones, M.Begley, C.Hill, C.G.Gahan, J.R.Marchesi. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci USA 2008; 105(36):13580–5; PMID:18757757; http://dx.doi.org/10.1073/pnas.0804437105
21. G.B.Kim, C.M.Miyamoto, E.A.Meighen, B.H.Lee. Cloning and characterization of the bile salt hydrolase genes (bsh) from Bifidobacterium bifidum strains. Appl Environ Microbiol 2004; 70(9):5603–12; PMID:15345449; http://dx.doi.org/10.1128/AEM.70.9.5603-5612.2004
22. R.S.Kumar, J.A.Brannigan, A.A.Prabhune, A.V.Pundle, G.G.Dodson, E.J.Dodson, C.G.Suresh. Structural and functional analysis of a conjugated bile salt hydrolase from Bifidobacterium longum reveals an evolutionary relationship with penicillin V acylase. J Biol Chem 2006 Oct 27; 281(43):32516–25; http://dx.doi.org/10.1074/jbc.M6041-72200
23. J.P.Coleman, L.L.Hudson. Cloning and characterization of a conjugated bile acid hydrolase gene from Clostridium perfringens. Appl Environ Microbiol 1995; 61(7):2514–20; PMID:7618863
24. J.M.Ridlon, D.J.Kang, P.B.Hylemon, J.S.Bajaj. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014; 30(3):332–8; PMID:24625896; http://dx.doi.org/10.1097/MOG.0000000000000057
25. J.Lin, O.Sahin, L.O.Michel, Q.Zhang. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect Immun 2003; 71(8):4250–59; PMID:12874300; http://dx.doi.org/10.1128/IAI.71.8.4250-4259.2003
26. A.Yokota, M.Veenstra, P.Kurdi, H.W.van Veen, W.N.Konings. Cholate resistance in Lactococcus lactis is mediated by an ATP-dependent multispecific organic anion transporter. J Bacteriol 2000; 182(18):5196–201; PMID:10960105; http://dx.doi.org/10.1128/JB.182.18.5196-5201.2000
27. M.L.Fernandez Murga, D.Bernick, G.F.de Valdez, A.E.Disalvo. Permeability and stability properties of membranes formed by lipids extracted from Lactobacillus acidophilus grown at different temperatures. Arch Biochem Biophys 1999; 364:115–121; PMID:10087172; http://dx.doi.org/10.1006/abbi.1998.1093
28. H.Kimoto, S.Ohmomo, T.Okamoto. Enhancement of bile tolerance in Lactococci by Tween 80. J Appl Micro 2002; 92:41–46; http://dx.doi.org/10.1046/j.1365-2672.2002.01505.x
29. Y.Liu, H.An, J.Zhang, J.Zhou, H.Zhou, F.Ren, Y.Hao. Functional role of tlyC1 encoding a hemolysin-like protein from Bifidobacterium longum BBMN68 in bile tolerance. FEMS Microbiol Lett 2014; 360:167–73; PMID:25227940; http://dx.doi.org/10.1111/1574-6968.12601
30. L.Ruiz, Y.Couté, B.Sánchez, C.G.de los Reyes-Gavilán, J.Sanchez, A.Margolles. The cell-envelope proteome of Bifidobacterium longum in an in vivo bile environment. Microbiology 2009; 155:957–67; PMID:19246766; http://dx.doi.org/10.1099/mic.0.024273-0
31. R.Coleman, P.J.Lowe, D.Billington. Membrane lipid composition and susceptibility to bile salt damage. Biochim Biophys Acta 1980; 599(1):294–300; PMID:7397151; http://dx.doi.org/10.1016/0005-2736(80)90075-9
32. D.M.Heuman, R.S.Bajaj, Q.Lin. Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. J Lipid Res 1996; 37(3):562–73; PMID:8728319
33. T.Fujisawa, M.Mori. Influence of bile salts on beta-glucuronidase activity of intestinal bacteria. Lett Appl Microbiol 1996; 22(4):271–74; PMID:8934784; http://dx.doi.org/10.1111/j.1472-765X.1996.tb01159.x
34. D.O.Noh, S.E.Gilliland. Influence of bile on cellular integrity and beta-galactosidase activity of Lactobacillus acidophilus. J Dairy Sci 1993; 76(5):1253–59; PMID:8505417; http://dx.doi.org/10.3168/jds.S0022-0302(93)77454-8
35. A.Gómez Zavagilia, G.Kociubinski, P.Pérez, E.Disalvo, G.De Antoni. Effect of bile on the lipid composition and surface properties of bifidobacteria. J Appl Microbiol 2002; 93(5):794–99; http://dx.doi.org/10.1046/j.1365-2672.2002.01747.x
36. M.P.Taranto, G.Perez-Martinez, G.Font de Valdez. Effect of bile acid on the cell membrane functionality of lactic acid bacteria for oral administration. Res Microbiol 2006; 157(8):720–25; PMID:16730163; http://dx.doi.org/10.1016/j.resmic.2006.04.002
37. M.Hofmann, C.Schumann, G.Zimmer, K.Henzel, U.Locher, U.Leuschner. LUV’s lipid composition modulates diffusion of bile acids. Chem Phys Lipid 2001; 110(2):165–71; http://dx.doi.org/10.1016/S0009-3084(01)00131-1
38. R.Schubert, H.Jaroni, J.Schoelmerich, K.H.Schmidt. Studies on the mechanism of bile salt-induced liposomal membrane damage. Digestion 1983; 28(3):181–90; PMID:6365666; http://dx.doi.org/10.1159/000198984
39. D.J.Cabral, D.M.Small, H.S.Lilly, J.A.Hamilton. Transbilayer movement of bile acids in model membranes. Biochemistry 1987; 26(7):1801–4; PMID:3593691; http://dx.doi.org/10.1021/bi00381a002
40. A.M.Prouty, W.H.Schwesinger, J.S.Gunn. Biofilm formation and interaction with the surfaces of gallstones by Salmonella spp. Infect Immunol 2002; 70:2640–49; http://dx.doi.org/10.1128/IAI.70.5.2640-2649.2002
41. M.A.Hildebrandt, C.Hoffman, S.A.SHerill-Mix, S.A.Keilbaugh, M.Hamady, Y.Y.Chen, R.Knight, R.S.Ahima, F.Bushman, G.D.Wu. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009; 137(5):1716–24; PMID:19706296; http://dx.doi.org/10.1053/j.gastro.2009.08.042
42. M.H.Floch, H.J.Binder, B.Filburn, W.Gershengorn. The effect of bile acids on intestinal microflora. Am J Clin Nutr 1972; (12):1418–26; PMID:4344803
43. P.Kurdi, K.Kawanishi, K.Mizutani, A.Yokota. Mechanism of growth inhibition by free bile acids in lactobacilli and bifidobacteria. J Bacteriol 2006; 188(5):1979–86; PMID:16484210; http://dx.doi.org/10.1128/JB.188.5.1979-1986.2006
44. J.P.Grill, C.Cayuela, J.M.Antoine, F.Schneider. Isolation and characterization of a Lactobacillus amylovorus mutant depleted in conjugated bile salt hydrolase activity: relation between activity and bile salt resistance. J Appl Microbiol 2000; 89:553–563; PMID:11054157; http://dx.doi.org/10.1046/j.1365-2672.2000.01147.x
45. O.Dussurget, D.Cabanes, P.Dehoux, M.Lecuit, C.Buchrieser, P.Glaser, P.Cossart, European Listeria Genome Consortoum. Mol Microbiol 2002; 10(5):238–45
46. O.Dussurget, D.Cabanes, P.Dehoux, M.Lecuit, C.Buchrieser, P.Glaser, P.Cossart; European Listeria Genome Consortium. Listeria monocytogenes bile salt hydrolase is a PrfA-regulated virulence factor involved in the intestinal and hepatic phases of listeriosis. Mol Microbiol 2002 Aug; 45(4):1095–106; http://dx.doi.org/10.1046/j.1365-2958.2002.03080.x
47. C.Dunne, L.O’Mahony, L.Murphy, G.Thornton, D.Morrissey, S.O’Halloran, M.Feeney, S.Flynn, G.Fitzgerald, C.Daly, In vitro selection criteria for probiotic bacteria of human origin: correlations with in vivo findings. Am J Clin Nutr 2001; 73(2 Suppl):386S–92S; PMID:11157346
48. S.M.Huijghebaert, H.J.Eyssen. Specificity of bile salt sulfatase activity from Clostridium sp. strains S1. Appl Environ Microbiol 1982; 44(5):1030–1034; PMID:7181500
49. J.Van Eldere, P.Celis, G.De Pauw, E.Lesaffre, H.Eyssen. Tauroconjugation of cholic acid stimulates 7 alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol 1996; 62(2):656–661; PMID:8593067
50. S.Devkota, Y.Wang, M.W.Musch, V.Leone, H.Fehlner-Peach, A.Nadimpalli, D.A.Antonopoulos, B.Jabri, E.B.Chang. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012; 487(7405):104–8; PMID:22722865
51. J.J.Guilbert. The world health report 2002-reducing risks, promoting healthy life. Educ Health 2003; 16(2):230; http://dx.doi.org/10.1080/1357628031000116808
52. M.F.Muldoon, S.B.Manuck, K.A.Matthews. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ 1990; 301:309–14; PMID:2144195; http://dx.doi.org/10.1136/bmj.301.6747.309
53. M.Evans, S.Roberts, S.Davies, A.Rees. Medical lipid-regulating therapy: current evidence, ongoing trails and future developments. Drugs 2004; 64(11):1181–96; PMID:15161326; http://dx.doi.org/10.2165/00003495-200464110-00003
54. M.L.Jones, C.Tomaro-Duchesneau, C.J.Martoni, S.Prakash. Cholesterol lowering with bile salt hydrolase-active probiotic bacteria, mechanism of action, clinical evidence, and future direction for heart health applications. Expert Opin Biol Ther 2013; 13(5):631–642; PMID:23350815; http://dx.doi.org/10.1517/14712598.2013.758706
55. M.Begley, C.Hill, C.G.Gahan. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol 2006; 72(3):1729–38; PMID:16517616; http://dx.doi.org/10.1128/AEM.72.3.1729-1738.2006
56. B.E.Gustafsson, T.Midvedt, A.Norman. Metabolism of cholic acid in germfree animals after the establishment in the intestinal tract of deconjugating and 7alpha-dehydroxylating bacteria. Acta Pathol Microbiol Scand 1968; 72(3):433–43; PMID:4297296; http://dx.doi.org/10.1111/j.1699-0463.1968.tb00457.x
57. S.Narushima, K.Itoha, Y.Miyamoto, S.H.Park, K.Nagata, K.Kuruma, K.Uchida. Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 2006; 41(9):835–43; PMID:17152920; http://dx.doi.org/10.1007/s11745-006-5038-1
58. J.E.Wells, F.Berr, L.A.Thomas, R.H.Dowling, P.B.Hylemon. Isolation and characterization of cholic acid 7alpha-dehydroxylating fecal bacteria from cholesterol gallstone patients. J Hepatol 2000; 32(1):4–10; PMID:10673060; http://dx.doi.org/10.1016/S0168-8278(00)80183-X
59. F.Takamine, T.Imamura. Isolation and characterization of bile acid 7-dehydroxylating bacteria from human feces. Microbiol Immunol 1995; 39(1):11–8; PMID:7783673; http://dx.doi.org/10.1111/j.1348-0421.1995.tb02162.x
60. S.Hirano, R.Nakama, M.Tamaki, N.Masuda, H.Oda. Isolation and characterization of thirteen intestinal microorganisms capable of 7alpha-dehydroxylating bile acids. Appl Environ Microbiol 1981; 41(3):737–45; PMID:7224633
61. H.J.Eyssen, G.De Pauw, J.Van Eldere. Formation of hyodeoxycholic acid from muricholic acid and hyocholic acid by an unidentified gram-positive rod termed HDCA-1 isolated from rat intestinal microflora. Appl Environ Microbiol 1999; 65(7):3158–63; PMID:10388717
62. E.C.Sacquet, D.P.Gadelle, M.J.Riottot, P.M.Raibaud. Absence of transformation of beta-muricholic acid by human microflora implanted in the digestive tracts of germfree male rats. Appl Environ Microbiol 1984; 47(5):1167–68; PMID:6742831
63. J.M.Ridlon, P.B.Hylemon. Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7alpha-dehydroxylating bacterium. J Lipid Res 2012; 53(1):66–76; PMID:22021638; http://dx.doi.org/10.1194/jlr.M020313
64. D.H.Mallonee, J.L.Adams, P.B.Hylemon. The bile acid-inducible baiB gene from Eubacterium sp. strain VPI 12708 encodes a bile acid-coenzyme A ligase. 1992; 174(7):2065–71; PMID:1551828
65. J.A.Dawson, D.H.Mallonee, I.Björkhem, P.B.Hylemon. Expression and characterization of a C24 bile acid 7 alpha-dehydratase from Eubacterium sp. strain VPI 12708 in Escherichia coli. J Lipid Res 1996; 37(6):1258–67; PMID:8808760
66. J.P.Coleman, W.B.White, P.B.Hylemon. Molecular cloning of bile acid 7-dehydroxylase from Eubacterium sp. strain VPI 12708. J Bacteriol 1987; 169(4):1516–21; PMID:3549693
67. nd, S.Barnes, P.B.Hylemon. Clostridium scindens baiCD and baiH genes encode stereo-specific 7alpha/7beta-hydroxy-3-oxo-delta-4-cholenoic acid oxidoreductases. Biochim Biophys Acta 2008; 1781(1-2):16–25; PMID:18047844; http://dx.doi.org/10.1016/j.bbalip.2007.10.008
68. J.Winter, G.N.Morris, S.O’Rourke-Locascio, V.D.Bokkenheuser, E.H.Mosbach, B.I.Cohen, P.B.Hylemon. Mode of action of steroid desmolase and reductases synthesized by Clostridium “scindens” (formerly Clostridium strain 19). J Lipid Res 1984; 25(10):1124–31; PMID:6512418
69. V.D.Bokkenheuser, G.N.Morris, A.E.Ritchie, L.V.Holdeman, J.Winter. Biosynthesis of androgen from cortisol by a species of Clostridium recovered from human fecal flora. J Infect Dis 1984; 149(4):489–94; PMID:6725987; http://dx.doi.org/10.1093/infdis/149.4.489
70. J.M.Ridlon, S.Ikegawa, J.M.Alves, B.Zhou, A.Kobayaski, T.Iida, K.Mitamura, G.Tanabe, M.Serrano, A.De Guzman, Clostridium scindens: a human gut microbe with high potential to convert glucocorticoids into androgens. J Lipid Res 2013; 54(9):2437–49; PMID:23772041; http://dx.doi.org/10.1194/jlr.M038869
71. J.M.Ridlon, J.S.Bajaj. The human gut sterolbiome: bile acid-microbiome endocrine aspects and therapeutics. Acta Pharmaceutica Sinica B 2015; 5(2):99–105; PMID:26579434; http://dx.doi.org/10.1016/j.apsb.2015.01.006
72. J.M.Ridlon, D.J.Kang, P.B.Hylemon. Isolation and characterization of a bile acid inducible 7alpha-dehydroxylating operon in Clostridium hylemonae TN271. Anaerobe 2010; 16(2):137–46; PMID:19464381; http://dx.doi.org/10.1016/j.anaerobe.2009.05.004
73. D.H.Mallonee, P.B.Hylemon. Sequencing and expression of a gene encoding a bile acid transporter from Eubacterium sp. strain VPI 12708. J Bacteriol 1996; 178(24):7053–58; PMID:8955384
74. D.H.Mallonee, M.A.Lijewski, P.B.Hylemon. Expression in Escherichia coli and characterization of a bile acid-inducible 3 alpha-hydroxysteroid dehydrogenase from Eubacterium sp. strain VPI 12708. Curr Microbiol 1995; 30(5):259–63; PMID:7766153; http://dx.doi.org/10.1007/BF00295498
75. S.Yoshimoto, T.M.Loo, K.Atarashi, H.Kanda, S.Sato, S.Oyadomari, Y.Iwakura, K.Oshima, H.Morita, M.Hattori, Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499(7456):97–101; PMID:23803760
76. J.Ou, F.Carbonero, E.G.Zoetendal, J.P.DeLany, M.Wang, K.Newton, H.R.Gaskins, S.J.O’Keefe. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013; 98(1):111–20; PMID:23719549; http://dx.doi.org/10.3945/ajcn.112.056689
77. L.A.David, C.F.Maurice, R.N.Carmody, D.B.Gootenberg, J.E.Button, B.E.Wolfe, A.V.Ling, A.S.Devlin, Y.Varma, M.A.Fischach, Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505(7484):559–63; PMID:24336217; http://dx.doi.org/10.1038/nature12820
78. D.J.O’Keefe, J.V.Li, L.Lahti, J.Ou, F.Carbonero, K.Mohammed, J.M.Posma, J.Kinross, E.Wahl, E.Ruder, Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun 2015; 6:6342; http://dx.doi.org/10.1038/ncomms7342
79. K.B.Islam, S.Fukiya, M.Hagio, N.Fujii, S.Ischizuka, T.Ooka, Y.Ogura, T.Hayashi, A.Yokota. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011; 141(5):1773–81; PMID:21839040; http://dx.doi.org/10.1053/j.gastro.2011.07.046
80. S.Bhowmik, D.H.Jones, H.P.Chiu, I.H.Park, H.J.Chiu, H.L.Axelrod, C.L.Farr, H.J.Tien, S.Agarwalla, S.A.Lesley. Structural and functional characterization of BaiA, an enzyme involved in secondary bile acid synthesis in human gut microbe. Proteins 2014; 82(2):216–29; PMID:23836456; http://dx.doi.org/10.1002/prot.24353
81. B.Bhowmik, H.-P.Chiu, D.H.Jones, H.-J.Chiu, M.D.Miller, Q.Xu, C.L.Farr, J.M.Ridlon, J.E.Wells, M.-A.Elsliger Structure and functional characterization of a Bile Acid 7α dehydratase BaiE in secondary bile acid synthesis. Proteins 2015; in press; PMID:26650892; http://dx.doi.org/10.1002/prot.2471 after 2015
82. J.T.Korpela, T.Fotsis, H.Adlercreutz. Multicomponent analysis of bile acids in faeces by anion exchange and capillary column gas-liquid chromatography: application in oxytetracycline treated subjects. J Steroid Biochem 1986; 25(2):277-84.7; PMID:3747527; http://dx.doi.org/10.1016/0022-4731(86)90429-2
83. G.Kakiyama, A.Muto, H.Takei, H.Nittono, T.Murai, T.Kurosawa, A.F.Hofmann, W.M.Pandak, J.S.Bajaj. A simple and accurate HPLC method for fecal bile acid profile in healthy and cirrhotic subjects: validation by GC-MS and LC-MS. J Lipid Res 2014; 55(5):978–90; PMID:24627129; http://dx.doi.org/10.1194/jlr.D047506
84. M.I.Kelsey, J.E.Molina, S.K.Huang, K.K.Hwang. The identification of microbial metabolites of sulfolithocholic acid. J Lipid Res 1980; 21(6)751–9.6; PMID:7419986
85. G.M.Benson, N.J.Haskins, C.Eckers, P.J.Moore, D.G.Reid, R.C.Mitchell, S.Waghmare, K.E.Suckling. Polydeoxycholate in human and hamster feces: a major product of cholate metabolism. J Lipid Res 1993; 34(12):2121–34.1; PMID:8301231
86. E.Studer, X.Zhou, R.Zhao, Y.Wang, K.Takabe, M.Nagahashi, W.M.Pandak, P.Dent, S.Spiegel, R.Shi, Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes. Hepatology 2012 Jan; 55(1):267–76; http://dx.doi.org/10.1002/hep.24681
87. J.R.Swann, E.J.Want, F.M.Geier, K.Spagou, I.D.Wilson, J.E.Sidaway, J.K.Nicholson, E.Holmes. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc Natl Acad Sci U S A 2009; 108 Suppl 1:4523–30
88. F.Berr, G.A.Kullak-Ublick, G.Paumgartner, W.Münzing, P.B.Hylemon. 7α-dehydroxylating bacteria enhance deoxycholic acid input and cholesterol saturation of bile in patients with gallstones. Gastroenterology 1996; 111(6):1611–201; PMID:8942741; http://dx.doi.org/10.1016/S0016-5085(96)70024-0
89. L.A.Thomas, M.J.Veysey, G.M.Murphy, D.Russell-Jones, G.L.French, J.A.Wass, R.H.Dowling. Octreotide induced prolongation of colonic transit increases faecal anaerobic bacteria, bile acid metabolising enzymes, and serum deoxycholic acid in patients with acromegaly Gut 2005; 54(5):630–5; PMID:15831907
90. D.M.Heuman. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30(5):719–30; PMID:2760545
91. K.Matsuoka, Y.Moroi. Micelle formation of sodium deoxycholate and sodium ursodeoxycholate (part 1). Biochim Biophys Acta. 2002; 1580(2-3):189–99; PMID:11880243; http://dx.doi.org/10.1016/S1388-1981(01)00203-7
92. A.S.Devlin, M.A.Fischbach. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol 2015; 11(9):685–90; PMID:26192599; http://dx.doi.org/10.1038/nchembio.1864
93. A.Odermatt, T.Da Cunha, C.A.Penno, C.Chandsawangbhuwana, C.Reichert, A.Wolf, M.Dong, M.E.Baker. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11beta-hydroxysteroid dehydrogenase 1. Biochem J 2011; 436(3):621–9; PMID:21453287; http://dx.doi.org/10.1042/BJ20110022
94. A.Odermatt, P.Klusonova. 11beta-Hydroxysteroid dehydrogenase 1: Regeneration of active glucocorticoids is only part of the story. J Steroid Biochem Mol Biol 2015; 151:85–92; PMID:25151952; http://dx.doi.org/10.1016/j.jsbmb.2014.08.011
95. K.Hase, L.Eckmann, J.D.Leopard, N.Varki, M.F.Kagnoff. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002; 70(2):953–63; PMID:11796631; http://dx.doi.org/10.1128/IAI.70.2.953-963.2002
96. Y.Campbell, M.L.Fantacone, A.F.Gombart. Regulation of antimicrobial peptide gene expression by nutrients and by-products of microbial metabolism. Eur J Nutr 2012; 51(8):899–907; PMID:22797470; http://dx.doi.org/10.1007/s00394-012-0415-4
97. H.Wang, J.Chen, K.Hollister, L.C.Sowers, B.M.Forman. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999; 3(5):543–53; PMID:10360171; http://dx.doi.org/10.1016/S1097-2765(00)80348-2
98. T.Fujino, M.Une, T.Imanaka, K.Inoue, T.Nishimaki-Mogami. Structure-activity relationship of bile acids and bile acid analogs in regard to FXR activation. J Lipid Res 2004; 45(1):132–8; PMID:13130122; http://dx.doi.org/10.1194/jlr.M300215-JLR200
99. K.Hase, M.Murakami, M.Iimura, S.P.Cole, Y.Horibe, T.Ohtake, Expression of LL-37 by human gastric epithelial cells as a potential host defense mechanism against Helicobacter pylori. Gastroenterology 2003; 125(6):1613–25; PMID:14724813; http://dx.doi.org/10.1053/j.gastro.2003.08.028
100. A.F.Hofmann, L.R.Hagey. Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades. J Lipid Res 2014; 55(8):1553–1595; http://dx.doi.org/10.1194/jlr.R049437
101. M.P.Guarino, S.Cocca, A.Altomare, S.Emerenziani, M.Cicala. Ursodeoxycholic acid therapy in gallbladder disease, a story not yet completed. World J. Gastroenterol 2013; 19(31):5029–5034
102. F.Czul, A.Peyton, C.Levy. Primary biliary cirrhosis: therapeutic advances. Clin Liver Dis 2013.17(2):229–242; PMID:23540499; http://dx.doi.org/10.1016/j.cld.2012.12.003
103. M.F.Mahmoud, S.M.Elshazly. Ursodeoxycholic acid ameliorates fructose-induced metabolic syndrome in rats. PLoS One 2014; 9(9):e106993; PMID:25202970; http://dx.doi.org/10.1371/journal.pone.0106993
104. D.S.ALberts, M.E.Martinez, L.M.Hess, J.G.Einspahr, S.B.Green, A.K.Bhattacharyya, J.Guillen, M.Krutzsch, A.K.Batta, G.Salen, et al, Phoenix and Tucson Gastroenterologist Networks. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005; 97(11):846–53; PMID:15928305; http://dx.doi.org/10.1093/jnci/dji144
105. L.Serfaty. Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro. Clin Res Hepatol Gastroenterol 2012; 36 Suppl 1:S53–S60; PMID:23141895; http://dx.doi.org/10.1016/S2210-7401(12)70022-0
106. E.J.Carey, K.D.Lindor. Chemoprevention of colorectal cancer with ursodeoxycholic acid: cons. Clin Res Hepatol Gastroenterol 2012; 36 Suppl 1:S61–S64
107. D.L.Earnest, H.Holubec, R.K.Wali, C.S.Jolley, M.Bissonette, A.K.Bhattacharyya, H.Roy, S.Khare, T.A.Brasitus. Chemoprevention of azomethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 1994 Oct 1; 54(19):5071–4
108. T.A.Brasitus. Primary chemoprevention strategies for colorectal cancer: ursodeoxycholic acid and other agents. Gastroenterology 1995; 109(6):2036–38; PMID:7498674; http://dx.doi.org/10.1016/0016-5085(95)90776-9
109. R.K.Wali, B.P.FrawleyJr, S.Hartmann, H.K.Roy, S.Khare, B.A.Scaglione-Sewell, D.L.Earnest, M.D.Sitrin, T.A.Brasitus, M.Bissonnette. Mechanism of action of chemopreventative ursodeoxycholate in the azomethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and –zeta. Cancer Res 1995 Nov 15; 55(22):5257–64
110. E.Im, J.D.Martinez. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. J Nutr 2004; 134(2):483–86; PMID:14747693
111. C.M.Rodrigues, G.Fan, P.Y.Wong, B.T.Kren, C.J.Steer. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 1998 Mar; 4(3):165–78
112. M.S.Kulkarni, P.M.Heidepriem, K.L.Yielding. Production by lithocholic acid of DNA strand breaks in L1210 cells. Cancer Res 1980; 40:2666–2669; PMID:7388816
113. L.A.Booth, I.T.Gilmore, R.F.Bilton. Secondary bile acid induced DNA damage in HT29 cells: are free radicals involved? Free Radic Res 1997; 26(2):135–44; PMID:9257125; http://dx.doi.org/10.3109/10715769709-097792
114. M.S.Kulkarni, B.A.Cox, K.L.Yielding. Requirements for induction of DNA strand breaks by lithocholic acid. Cancer Res 1982; 42(7):2792–95; PMID:7083168
115. M.Rupnik, M.H.Wilcox, D.N.Gerding. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nature Rev Microbiol 2009; 7:526–536; http://dx.doi.org/10.1038/nrmicro2164
116. F.C.Lessa, Y.Mu, W.M.Bamberg, Z.G.Beldavs, G.K.Dumyati, J.R.Dunn, M.M.Farley, S.M.Holzbauer, J.I.Meek, E.C.Phipps, Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 26; 372(9):825–34; http://dx.doi.org/10.1056/NEJMoa1408913
117. K.H.Wilson, F.Perini. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun 1988; 56:2610–14; PMID:3417352
118. S.A.Kuehne, S.T.Cartman, J.T.Heap, M.L.Kelly, A.Cockayne, N.P.Minton. The role of toxin A and toxin B in Clostridium difficile infection. Nature 2010; 467(7316):711–3; PMID:20844489; http://dx.doi.org/10.1038/nature09397
119. E.van Nood, A.Vrieze, M.Nieuwdorp, S.Fuentes, E.G.Zoetendal, W.M.de Vos, C.E.Visser, E.J.Kuijper, J.F.Bartelsman, J.G.Tijssen, Duodenal infusion of feces for recurrent Clostridium difficile. N Engl J Med 2013; 368(22):407–415; PMID:23323867; http://dx.doi.org/10.1056/NEJMoa1205037
120. C.G.Buffie, V.Bucci, R.R.Stein, P.T.McKenney, L.Ling, A.Gobourne, D.No, H.Liu, M.Kinnebrew, A.Viale Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517(7533):205–8; PMID:25337874; http://dx.doi.org/10.1038/nature13828
121. K.H.Wilson. Eficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol 1983; (4):1017–9
122. K.H.Wilson, M.J.Kennedy, F.R.Fekety. Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile J Clin Microbiol 1982; (3):443–6
123. J.A.Sorg, A.L.Sonenshein. Bile salts and glycine as cogerminants for Clostridium difficile spores. J Bacteriol 2008; 190(7):2505–12; PMID:18245298; http://dx.doi.org/10.1128/JB.01765-07
124. J.A.Sorg, A.L.Sonenshein. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol 2010; 192(19):4983–90; PMID:20675492; http://dx.doi.org/10.1128/JB.00610-10
125. M.B.Francis, C.A.Allen, J.A.Sorg. Muricholic acids inhibit Clostridium difficile spore germination and growth. PLoS One 2013; 8(9):e73653; PMID:24040011; http://dx.doi.org/10.1371/journal.pone.0073653
126. M.B.Francis, C.A.Allen, R.Shrestha, J.A.Sorg. Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog 2013; 9(5):e1003356; PMID:23675301; http://dx.doi.org/10.1371/journal.ppat.1003356